SCHEMBL2857162

SCHEMBL2857162

O=C(O)c1cc(F)nc(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ HCAR1 Q9BXC0 1/20 0.48
▸ HCAR2 Q8TDS4 1/20 0.46
▸ CA12 O43570 2/20 0.46
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA7 P43166 2/20 0.46
▸ CA9 Q16790 2/20 0.46
▸ CA14 Q9ULX7 2/20 0.46
▸ TPMT P51580 3/20 0.44
▸ TP53 P04637 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CA3 P07451 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ SELL P14151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20202139 0.84 TSHR (0.45) TSHRALOX15HIF1AHCAR1HCAR2
SCHEMBL20225494 0.84 TPMT (0.46) TSHRALOX15HIF1AHCAR1HCAR2
SCHEMBL11964240 0.81 ALOX15 (0.42) TSHRALOX15HIF1AHCAR1MAPT
SCHEMBL28304077 0.80 KDM4E (0.56) TSHRALOX15HIF1ACA12CA1
SCHEMBL22972017 0.77 PARP1 (0.45) TSHRLMNAMAPTSMN1; SMN2HSD17B10
SCHEMBL2859980 0.77 ALDH1A1 (0.33) TSHRALOX15HIF1AHCAR2ALDH1A1
SCHEMBL17371701 0.75 ALDH1A1 (0.42) TSHRKDM4EALDH1A1MAPTHPGD
SCHEMBL26189 0.73 CA12 (0.65) TSHRALOX15HIF1AHCAR1CA12
SCHEMBL22982 0.73 CA12 (0.65) TSHRALOX15HIF1AHCAR1CA12
SCHEMBL336433 0.72 HCAR1 (0.73) TSHRALOX15HIF1AHCAR1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118930884-A Fluorine-containing metal organic framework material for methane and nitrogen separation, and preparation method and application thereof 浙江工业大学 2024-11-12 — — CN claimed
CN-110818629-A Method for synthesizing fluoroisonicotinic acid derivative 杭州勇诚睿生物科技有限公司 2020-02-21 — — CN claimed
US-20260132133-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF KUMQUAT BIOSCIENCES INC (US) 2026-05-14 — — US disclosed
EP-4010330-B1 QUINOLINE DERIVATIVES AS PROTEIN KINASE INHIBITORS HIRUNDO BIOSCIENCES (BE) 2025-10-01 — — EP disclosed
WO-2025109475-A1 SHP-1 AGONISTS DANA-FARBER CANCER INSTITUTE, INC. (US) 2025-05-30 — — WO disclosed
EP-4511128-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF Kumquat Biosciences Inc. (US) 2025-02-26 — — EP disclosed
US-12195465-B2 Macrocyclic heterocycles and uses thereof KUMQUAT BIOSCIENCES INC. (US) 2025-01-14 — — US disclosed
CN-119095849-A Macrocyclic heterocycles and uses thereof 金橘生物科技公司 2024-12-06 — — CN disclosed
US-12156523-B2 Plant disease control agent MMAG CO., LTD. (JP) 2024-12-03 — — US disclosed
CN-118930884-A Fluorine-containing metal organic framework material for methane and nitrogen separation, and preparation method and application thereof 浙江工业大学 2024-11-12 — — CN disclosed
US-20240208975-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2024-06-27 — — US disclosed
WO-2014060493-A2 N-(PYRIDIN-2-YL)PYRIMIDIN-4-AMINE DERIVATIVES CONTAINING A SULFONE GROUP BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-04-24 — — WO disclosed
WO-2014060375-A2 5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFONE GROUP BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-04-24 — — WO disclosed
WO-2010107384-A1 ASPARTYL PROTEASE INHIBITORS MEDIVIR AB (SE) 2010-09-23 — — WO disclosed
WO-2010107384-A1 ASPARTYL PROTEASE INHIBITORS MEDIVIR AB (SE) 2010-09-23 — — WO disclosed
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 — — US disclosed
EP-2174931-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME Sumitomo Chemical Company, Limited (JP) 2010-04-14 — — EP disclosed
EP-0268775-B1 METHOD FOR PROTECTING PLANTS AGAINST DISEASES CIBA-GEIGY AG (CH) 1992-12-23 — — EP disclosed
US-4968344-A FUNGICIDES, BACTERICIDES CIBA-GEIGY CORPORATION (US) 1990-11-06 — — US disclosed
EP-0268775-A1 Method for protecting plants against diseases CIBA-GEIGY AG (CH) 1988-06-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208975-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF HRAS, KRAS, TP53 TSHR 2022/4885ALOX15 4767/4885HIF1A 3782/4885
US-12156523-B2 Plant disease control agent BROX, ALG1, CTRL TSHR 4374/4885ALOX15 1387/4885HIF1A 1395/4885
US-20260132133-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF KRAS, HRAS, BCL6 TSHR 371/4885ALOX15 3716/4885HIF1A 2986/4885
US-12195465-B2 Macrocyclic heterocycles and uses thereof HRAS, KRAS, TP53 TSHR 2022/4885ALOX15 4767/4885HIF1A 3782/4885
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME NAAA, NAT1, SAT1 TSHR 3394/4885ALOX15 1738/4885HIF1A 2136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback